CRDF Cardiff Oncology, Inc.
$1.21▲ +0.00%
Healthcare
Other
After hours
$1.20▼ -0.83%
Sep 11, 7:30 PM ET
Volume 493.3K
Avg Volume (10D) 613.2K
Key Metrics & Fundamentals
Market Cap
$94.13M
P/E Ratio
–
Div Yield
–%
52W Range
0.76 - 3.31
% vs 50 MA
19.75%
% vs 200 MA
-28.85%
RSI-14
66.8
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.99
Free Cash Flow
-$11.81M
Gross Rev
$104,000
Gross Profit
$104,000
EBITDA
-$9.62M
COGS
–
Operating Exp
$9.72M
Operating Income
-$9.62M
EBIT
-$9.62M
Pretax Income
-$9.23M
Net Income
-$9.23M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Cardiff Oncology to Participate in September 2026 Conferences
GlobeNewswire · Sep 2, 2026 11:00 AM
CRDF: Second Quarter Earnings
Zacks Small Cap Research · Aug 17, 2026 9:47 AM
William Blair Downgrades Cardiff Oncology to Market Perform From Outperform
MT Newswires · Aug 12, 2026 11:34 AM
Cardiff Oncology: Q2 Earnings Snapshot
Associated Press · Aug 11, 2026 8:46 PM
Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
GlobeNewswire · Aug 11, 2026 8:10 PM
Cardiff Oncology Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing
MT Newswires · Jul 16, 2026 8:08 PM
Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital
InvestorsHub · Jul 15, 2026 2:54 PM
Cardiff Oncology to Raise $10 Million in Share, Warrant Sale
MT Newswires · Jul 15, 2026 12:45 PM
Cardiff Oncology Announces $10 Million Registered Direct Offering
GlobeNewswire · Jul 15, 2026 12:00 PM
Is Cardiff Oncology, Inc. (CRDF) Stock Undervalued Amid Legal Uncertainty and Future Cancer Drug Potential?
Insider Monkey · Jun 30, 2026 1:06 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CRDF's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.